These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1142 related items for PubMed ID: 6151891

  • 1. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN.
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [Abstract] [Full Text] [Related]

  • 2. Comparison of labetalol with other anti-hypertensive drugs.
    Prichard BN, Richards DA.
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive drugs in pregnancy.
    Naden RP, Redman CW.
    Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
    [Abstract] [Full Text] [Related]

  • 4. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
    Rosei EA, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI, Trust PM.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ, McNeil JJ, Drummer OH.
    Drugs; 1984 Aug; 28 Suppl 2():16-34. PubMed ID: 6151889
    [Abstract] [Full Text] [Related]

  • 6. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH.
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [Abstract] [Full Text] [Related]

  • 7. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P.
    Drugs; 1984 Nov; 28 Suppl 2():35-50. PubMed ID: 6151890
    [Abstract] [Full Text] [Related]

  • 8. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
    Rosei EA, Fraser R, Morton JJ, Brown JJ, Lever AF, Robertson JI, Trust PM.
    Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
    [No Abstract] [Full Text] [Related]

  • 9. Labetalol in long-term treatment of hypertension.
    Prichard BN, Boakes AJ.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
    [Abstract] [Full Text] [Related]

  • 10. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
    Lamming GD, Broughton Pipkin F, Symonds EM.
    Clin Exp Hypertens (1978); 1980 Aug 26; 2(5):865-95. PubMed ID: 7428566
    [Abstract] [Full Text] [Related]

  • 13. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
    Michelson EL, Frishman WH.
    Ann Intern Med; 1983 Oct 26; 99(4):553-5. PubMed ID: 6137987
    [Abstract] [Full Text] [Related]

  • 14. [Combined alpha and beta adrenergic receptor blockade in the treatment of renal hypertension].
    Stummvoll HK.
    Wien Med Wochenschr Suppl; 1981 Oct 26; 69():14-6. PubMed ID: 6123200
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O, Sudoh K, Shibasaki M, Nakagawa C, Honda K.
    J Cardiovasc Pharmacol; 1994 Nov 26; 24(5):794-802. PubMed ID: 7532758
    [Abstract] [Full Text] [Related]

  • 16. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
    MacCarthy EP, Bloomfield SS.
    Pharmacotherapy; 1983 Nov 26; 3(4):193-219. PubMed ID: 6310529
    [Abstract] [Full Text] [Related]

  • 17. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD, Symonds EB.
    Br J Clin Pharmacol; 1979 Nov 26; 8(Suppl 2):217S-222S. PubMed ID: 526404
    [Abstract] [Full Text] [Related]

  • 18. Labetalol in hypertension.
    Lancet; 1977 May 28; 1(8022):1147-8. PubMed ID: 68239
    [No Abstract] [Full Text] [Related]

  • 19. Hypertension in pregnancy. Pathophysiology and management.
    Lubbe WF.
    Drugs; 1984 Aug 28; 28(2):170-88. PubMed ID: 6147240
    [Abstract] [Full Text] [Related]

  • 20. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT, Levy GP.
    Br J Clin Pharmacol; 1976 Aug 28; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.